Samsara BioCapital »

Coherus Biosciences shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Coherus Biosciences (CHRS) shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Coherus Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Coherus Biosciences held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coherus Biosciences by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.8M 3.4M 1.69

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Mineralys Therapeutics (MLYS)
Alumis (ALMS)
Septerna (SEPN)
Kalaris Therapeutics (KLRS)
Spyglass Pharma Com Shs
Neurogene (NGNE)
Inventiva Sa Ads (IVA)
Sutro Biopharma Com Shs (STRO)
Jade Biosciences Com New (JBIO)
Vtv Therapeutics Cl A New (VTVT)
Aquestive Therapeutics (AQST)
X4 Pharmaceuticals Com New (XFOR)
Nkarta (NKTX)
Arcellx Common Stock (ACLX)

View all positions for Samsara BioCapital

Top funds holding Coherus Biosciences

BlackRock
Vanguard Group
Vanguard Capital Management
Samsara BioCapital
Geode Capital Management
Kohlberg Kravis Roberts & Co
Two Sigma Investments
Alyeska Investment Group
State Street Corporation
CM Management
CAM Group Holding A/S
Tang Capital Management
Hudson Bay Capital Management
PanAgora Asset Management
Propel Bio Management

View all funds holding Coherus Biosciences